GlassScriptPhysician profile
Cecelia A Rondou
NPI 1285950147
$1,617.47
in general payments reported to CMS, 2019-2025
13 companies · $386 in 2025
The $386 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $211 · 2022: $367 · 2023: $273 · 2024: $380 · 2025: $386.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $722 · Education: $72.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $722.39 |
| Education | $72.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $513.00 | 2022-2025 | |
| Astellas Pharma US INC | $194.93 | 2022-2024 | Veozah, Myrbetriq |
| Organon LLC | $174.26 | 2021-2025 | Nexplanon |
| Hologic Sales and Service, LLC | $164.81 | 2021-2022 | |
| Biogen, INC. | $51.44 | 2024-2025 | Zurzuvae |
| Pfizer INC. | $48.43 | 2023-2025 | |
| Myovant Sciences INC. | $48.27 | 2021-2022 | |
| Evofem Biosciences, INC. | $45.19 | 2021-2022 | |
| Abbvie INC. | $37.72 | 2021-2022 | |
| Therapeuticsmd, INC. | $29.41 | 2021 | |
| Avanos Medical | $28.79 | 2023 | On-Q* Pump and Accessories |
| Abbott Laboratories | $19.46 | 2021 | |
| Roche Diagnostics Corporation | $18.21 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cecelia Rondou listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.